Bio-Inspired Albumin Platform for Synergistic Co-Delivery of Tanespimycin, Dasatinib, and Quercetin and Enhanced Therapeutic Efficacy in Triple-Negative Breast Cancer. (PubMed, Adv Healthc Mater) - Sep 9, 2026 - "(T-D-Q)-BSA Cs also inhibited TNBC-based tumor growth in two zebrafish xenograft in vivo models. In conclusion, the efficacy of (T-D-Q)-BSA Cs as a novel therapeutic strategy to eradicate TNBC in vitro and in vivo was demonstrated."
Journal • Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • IL6
|
|
?ukasz Licho?; Agnieszka Krogul-Sobczak; Andrzej Gamian; Anna Boguszewska-Czubara; Anna Wawruszak; Bernadetta Oklejewicz; Jakub Starzyk; Krzysztof Pawlik; Maciej Wnuk; Paulina Stec
|